Donnadieu, Emmanuel;
Luu, Maik;
Alb, Miriam;
Anliker, Brigitte;
Arcangeli, Silvia;
Bonini, Chiara;
De Angelis, Biagio;
... Casucci, Monica; + view all
(2022)
Time to evolve: predicting engineered T cell-associated toxicity with next-generation models.
Journal for ImmunoTherapy of Cancer
, 10
(5)
, Article e003486. 10.1136/jitc-2021-003486.
Preview |
Text
e003486.full.pdf - Published Version Download (11MB) | Preview |
Abstract
Despite promising clinical results in a small subset of malignancies, therapies based on engineered chimeric antigen receptor and T-cell receptor T cells are associated with serious adverse events, including cytokine release syndrome and neurotoxicity. These toxicities are sometimes so severe that they significantly hinder the implementation of this therapeutic strategy. For a long time, existing preclinical models failed to predict severe toxicities seen in human clinical trials after engineered T-cell infusion. However, in recent years, there has been a concerted effort to develop models, including humanized mouse models, which can better recapitulate toxicities observed in patients. The Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy (T2EVOLVE) consortium is a public-private partnership directed at accelerating the preclinical development and increasing access to engineered T-cell therapy for patients with cancer. A key ambition in T2EVOLVE is to design new models and tools with higher predictive value for clinical safety and efficacy, in order to improve and accelerate the selection of lead T-cell products for clinical translation. Herein, we review existing preclinical models that are used to test the safety of engineered T cells. We will also highlight limitations of these models and propose potential measures to improve them.
| Type: | Article |
|---|---|
| Title: | Time to evolve: predicting engineered T cell-associated toxicity with next-generation models |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1136/jitc-2021-003486 |
| Publisher version: | http://dx.doi.org/10.1136/jitc-2021-003486 |
| Language: | English |
| Additional information: | © Author(s) (or their employer[s]) 2022. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license (http://creativecommons.org/licenses/by-nc/4.0/). |
| UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10149206 |
Archive Staff Only
 |
View Item |
